Barclays Has Lowered Expectations for Addus HomeCare (NASDAQ:ADUS) Stock Price

Addus HomeCare (NASDAQ:ADUS) had its price objective reduced by equities research analysts at Barclays from $112.00 to $102.00 in a research report issued on Wednesday,Benzinga reports. The firm presently has an “underweight” rating on the stock. Barclays‘s price target suggests a potential upside of 3.42% from the stock’s current price.

ADUS has been the subject of several other reports. Truist Financial set a $135.00 target price on shares of Addus HomeCare and gave the company a “buy” rating in a research note on Wednesday, January 7th. Wall Street Zen cut shares of Addus HomeCare from a “strong-buy” rating to a “buy” rating in a report on Saturday. Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $139.00 price target on shares of Addus HomeCare in a report on Wednesday, February 25th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Addus HomeCare in a research note on Wednesday, January 21st. Finally, KeyCorp reissued an “overweight” rating on shares of Addus HomeCare in a report on Wednesday, February 25th. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, two have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $133.22.

Addus HomeCare Trading Down 0.7%

Shares of NASDAQ:ADUS opened at $98.63 on Wednesday. The company has a current ratio of 1.80, a quick ratio of 1.80 and a debt-to-equity ratio of 0.11. Addus HomeCare has a 12-month low of $91.35 and a 12-month high of $124.43. The business has a 50 day moving average of $106.46 and a two-hundred day moving average of $111.39. The company has a market capitalization of $1.84 billion, a PE ratio of 19.23, a PEG ratio of 1.39 and a beta of 0.92.

Insiders Place Their Bets

In other news, EVP David W. Tucker sold 379 shares of the firm’s stock in a transaction dated Wednesday, February 25th. The shares were sold at an average price of $105.36, for a total value of $39,931.44. Following the transaction, the executive vice president directly owned 10,423 shares of the company’s stock, valued at approximately $1,098,167.28. This trade represents a 3.51% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, EVP Darby Anderson sold 396 shares of the company’s stock in a transaction dated Wednesday, February 25th. The shares were sold at an average price of $105.36, for a total transaction of $41,722.56. Following the sale, the executive vice president directly owned 46,246 shares of the company’s stock, valued at approximately $4,872,478.56. This represents a 0.85% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders sold 16,610 shares of company stock valued at $1,768,970. Corporate insiders own 4.50% of the company’s stock.

Institutional Investors Weigh In On Addus HomeCare

Several hedge funds and other institutional investors have recently made changes to their positions in ADUS. Global Retirement Partners LLC grew its holdings in Addus HomeCare by 395.7% in the 4th quarter. Global Retirement Partners LLC now owns 233 shares of the company’s stock valued at $25,000 after buying an additional 186 shares in the last quarter. Larson Financial Group LLC boosted its holdings in Addus HomeCare by 133.3% in the 3rd quarter. Larson Financial Group LLC now owns 238 shares of the company’s stock valued at $28,000 after purchasing an additional 136 shares during the last quarter. Acumen Wealth Advisors LLC purchased a new stake in shares of Addus HomeCare in the 4th quarter valued at approximately $29,000. Private Trust Co. NA raised its position in shares of Addus HomeCare by 65.5% during the 4th quarter. Private Trust Co. NA now owns 283 shares of the company’s stock valued at $30,000 after buying an additional 112 shares during the period. Finally, Arax Advisory Partners lifted its holdings in Addus HomeCare by 95.8% in the fourth quarter. Arax Advisory Partners now owns 280 shares of the company’s stock valued at $30,000 after acquiring an additional 137 shares during the last quarter. Institutional investors and hedge funds own 95.35% of the company’s stock.

Addus HomeCare Company Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.